Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1,943 | 3 | 90.6% |
| Education | $186.34 | 4 | 8.7% |
| Food and Beverage | $15.30 | 1 | 0.7% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma Inc | $1,163 | 2 | $0 (2022) |
| PFIZER INC. | $780.00 | 1 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $201.64 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,163 | 2 | Astellas Pharma Inc ($1,163) |
| 2021 | $780.00 | 1 | PFIZER INC. ($780.00) |
| 2019 | $186.34 | 4 | Otsuka America Pharmaceutical, Inc. ($186.34) |
| 2017 | $15.30 | 1 | Otsuka America Pharmaceutical, Inc. ($15.30) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2022 | Astellas Pharma Inc | — | — | Cash or cash equivalent | $1,097.00 | Research |
| Study: A Study of ASP0367 in People With Kidneys That do Not Work Well and in Healthy People | ||||||
| 12/12/2022 | Astellas Pharma Inc | — | — | Cash or cash equivalent | $66.00 | Research |
| Study: A Study of ASP0367 in People With Kidneys That do Not Work Well and in Healthy People | ||||||
| 08/11/2021 | PFIZER INC. | LORBRENA (Drug) | — | In-kind items and services | $780.00 | Research |
| Study: LORLATINIB CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 12/12/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Education | In-kind items and services | $61.20 | General |
| Category: NEPHROLOGY | ||||||
| 12/12/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Education | In-kind items and services | $61.20 | General |
| Category: NEPHROLOGY | ||||||
| 07/31/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Education | In-kind items and services | $61.20 | General |
| Category: NEPHROLOGY | ||||||
| 03/13/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Education | In-kind items and services | $2.74 | General |
| Category: NEPHROLOGY | ||||||
| 07/31/2017 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: NEPHROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Study of ASP0367 in People With Kidneys That do Not Work Well and in Healthy People | Astellas Pharma Inc | $1,163 | 2 |
| LORLATINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $780.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 556 | 1,056 | $463,123 | $127,754 |
| 2022 | 12 | 612 | 1,155 | $505,750 | $147,841 |
| 2021 | 11 | 651 | 1,349 | $557,409 | $168,414 |
| 2020 | 14 | 812 | 1,491 | $657,205 | $179,762 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 42 | 276 | $144,819 | $62,115 | 42.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 99 | 107 | $93,368 | $14,042 | 15.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 136 | 220 | $69,003 | $13,123 | 19.0% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 36 | 81 | $34,270 | $12,416 | 36.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 64 | 149 | $39,396 | $8,017 | 20.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 49 | 78 | $35,155 | $6,975 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 82 | $21,502 | $5,796 | 27.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 32 | $19,053 | $3,164 | 16.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 17 | $6,320 | $1,987 | 31.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 14 | $238.00 | $117.60 | 49.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 49 | 304 | $158,992 | $69,492 | 43.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 152 | 274 | $116,436 | $20,886 | 17.9% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 45 | 95 | $39,900 | $15,207 | 38.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 75 | 76 | $62,482 | $11,284 | 18.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 100 | $25,799 | $8,674 | 33.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 65 | 130 | $32,331 | $7,321 | 22.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 61 | 84 | $24,888 | $4,588 | 18.4% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 24 | 24 | $16,704 | $3,214 | 19.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $8,854 | $2,259 | 25.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 14 | $5,269 | $1,970 | 37.4% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 13 | 27 | $8,021 | $1,814 | 22.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $6,074 | $1,134 | 18.7% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 56 | 400 | $209,200 | $91,720 | 43.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 161 | 292 | $123,369 | $22,741 | 18.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 114 | 120 | $98,541 | $18,424 | 18.7% |
About Dr. George Canas, M.D
Dr. George Canas, M.D is a Nephrology healthcare provider based in Brooklyn Center, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922025774.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Canas, M.D has received a total of $2,145 in payments from pharmaceutical and medical device companies, with $1,163 received in 2022. These payments were reported across 8 transactions from 3 companies. The most common payment nature is "" ($1,943).
As a Medicare-enrolled provider, Canas has provided services to 2,631 Medicare beneficiaries, totaling 5,051 services with total Medicare billing of $623,771. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Brooklyn Center, MN
- Active Since 07/17/2006
- Last Updated 03/11/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1922025774
Products in Payments
- LORBRENA (Drug) $780.00
- SAMSCA (Drug) $198.90
- JYNARQUE (Drug) $2.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Brooklyn Center
Anna Krieger, Md, MD
Nephrology — Payments: $219.69
Carl Dean, M.d, M.D
Nephrology — Payments: $61.20
Maxwell Leither
Nephrology — Payments: $48.84
Kyle Onan, Do, DO
Nephrology — Payments: $39.65
Daniel Ries, M.d, M.D
Nephrology — Payments: $35.27
Brady Brabec
Nephrology — Payments: $23.12